Wang, X., Yin, X., Sun, W., Bai, J., Shen, Y., Ao, Q., Gu, Y. and Liu, Y. (2017) Intravenous Infusion Umbilical Cord-Derived Mesenchymal Stem Cell in Primary Immune Thrombocytopenia: A Two-Year Follow-Up. Experimental and Therapeutic Medicine, 13, 2255-2258.
https://doi.org/10.3892/etm.2017.4229

has been cited by the following article:

• TITLE: Review: Umbilical Cord Stem Cells

  AUTHORS: Joseph Ignatius Azzopardi, Renald Blundell

  KEYWORDS: Umbilical Cord, Haematopoietic Stem Cells, Mesenchymal Stem Cells, Stem Cell Banking

  JOURNAL NAME: Stem Cell Discovery, Vol.8 No.1, January 30, 2018

  ABSTRACT: The use of umbilical cord blood as an alternative to bone marrow as a source of haematopoietic stem cells for the treatment of certain diseases has been on an increase since the first transplantation of umbilical cord-derived stem cells in 1988. In this paper, 6 of the latest case studies about the use of such stem cells have been discussed and are used as evidence to confirm the potential use of the umbilical cord as a source of haematopoietic stem cells for transplantation as treatment to various diseases. The debate over whether umbilical cord blood should be stored and why public banking facilities are preferred over those that are private have also been discussed in this paper.